创新药的牛市还在继续。今年以来,截至7月28日收盘,港股恒生药品及生物科技行业155家公司中,54家实现股价翻倍。其中,康诺亚表现尤为亮眼:股价从27.05港元的低点攀升至63.9港元,涨幅超130%,7月17日单日涨幅更达26.2%,成为资金追捧的焦点。资本市场的表现往往是企业价值的映射,这家成立不到十年的中国生物制药企业,正以独特的商业化路径和创新的出海模式,在全球医药舞台崭露头角。1行业黑马...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.